Q2 2025 13F Holders as of 30 Jun 2025
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
150,858,761
-
Total 13F shares
-
135,973,420
-
Share change
-
+2,582,830
-
Total reported value
-
$3,861,676,519
-
Put/Call ratio
-
43%
-
Price per share
-
$28.40
-
Number of holders
-
205
-
Value change
-
+$69,697,401
-
Number of buys
-
108
-
Number of sells
-
111
Institutional Holders of Avidity Biosciences, Inc. - Common Stock (RNA) as of Q2 2025
As of 30 Jun 2025,
Avidity Biosciences, Inc. - Common Stock (RNA) was held by
205 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
135,973,420 shares.
The largest 10 holders included
FMR LLC, PRICE T ROWE ASSOCIATES INC /MD/, JANUS HENDERSON GROUP PLC, RTW INVESTMENTS, LP, BlackRock, Inc., WELLINGTON MANAGEMENT GROUP LLP, VANGUARD GROUP INC, RA CAPITAL MANAGEMENT, L.P., Avoro Capital Advisors LLC, and STATE STREET CORP.
This page lists
205
institutional shareholders reporting positions in this security
for the Q2 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.